Chen M, Hankins JS, Zhang M, Ataga KI, et al. Comparative pharmacovigilance assessment of adverse events associated with the use of hydroxyurea, L-glutamine, voxelotor, and crizanlizumab in sickle cell disease. Am J Hematol 2024;99:E37-E41.
PMID: 37950855